Agrium Takes Equity Stake in CH Biotech R&D
6 November 2014 
Agrium Inc. subsidiary Loveland Products has signed a definitive agreement to take an equity stake in Taiwan-based CH Biotech, giving Agrium the right to obtain exclusive, worldwide distribution rights to CH Biotech’s existing plant health technologies as well as access to new product and technology opportunities.
The agreement allows CH Biotech, an agricultural technology company that develops and markets plant health and nutrition technologies, to further collaborate with Agrium to expand their plant health-focused research and development initiatives.
“This integrated strategic partnership and investment continues to build our offering of next-generation plant health technologies, allowing us to provide a diverse and highly complementary product portfolio to meet the changing needs of our grower customers around the world,” said Brent Smith, Vice President of Agrium’s Loveland Products.
Agrium’s Loveland Products currently markets and distributes several CH Biotech technologies including the brands Radiate, NutriSync and Consensus, which are product technologies focused on improving root development, stress reduction, and nutrient utilization.
Read more about the transaction here.
Get The Newsletter Today!
